Literature DB >> 10614011

Differential expression of MHC class II isotype chains.

C Alcaïde-Loridan1, A M Lennon, M R Bono, R Barbouche, K Dellagi, M Fellous.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10614011     DOI: 10.1016/s1286-4579(99)00224-5

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


× No keyword cloud information.
  6 in total

1.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Isolation of the promoters of Atlantic salmon MHCII genes.

Authors:  Mohasina Syed; Olav Vestrheim; Birthe Mikkelsen; Maria Lundin
Journal:  Mar Biotechnol (NY)       Date:  2003 May-Jun       Impact factor: 3.619

3.  A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.

Authors:  Denise M McKinney; Scott Southwood; Denise Hinz; Carla Oseroff; Cecilia S Lindestam Arlehamn; Veronique Schulten; Randy Taplitz; David Broide; Willem A Hanekom; Thomas J Scriba; Robert Wood; Rafeul Alam; Bjoern Peters; John Sidney; Alessandro Sette
Journal:  Immunogenetics       Date:  2013-02-08       Impact factor: 2.846

4.  Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression.

Authors:  Barry Slobedman; J Lewis Stern; Anthony L Cunningham; Allison Abendroth; Davide A Abate; Edward S Mocarski
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.

Authors:  Ma Luo; Joanne Embree; Suzie Ramdahin; Thomas Bielawny; Tyler Laycock; Jeffrey Tuff; Darren Haber; Mariel Plummer; Francis A Plummer
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

6.  Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease.

Authors:  Anne S De Groot; Ankit K Desai; Sandra Lelias; S M Shahjahan Miah; Frances E Terry; Sundos Khan; Cindy Li; John S Yi; Matt Ardito; William D Martin; Priya S Kishnani
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.